These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 24041034)

  • 1. Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection.
    Cashin K; Jakobsen MR; Sterjovski J; Roche M; Ellett A; Flynn JK; Borm K; Gouillou M; Churchill MJ; Gorry PR
    Retrovirology; 2013 Sep; 10():98. PubMed ID: 24041034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype.
    Nedellec R; Coetzer M; Shimizu N; Hoshino H; Polonis VR; Morris L; Mårtensson UE; Binley J; Overbaugh J; Mosier DE
    J Virol; 2009 Sep; 83(17):8353-63. PubMed ID: 19553323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
    Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia.
    Nedellec R; Herbeck JT; Hunt PW; Deeks SG; Mullins JI; Anton ED; Reeves JD; Mosier DE
    AIDS Res Hum Retroviruses; 2017 Mar; 33(3):234-245. PubMed ID: 27604829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-2 interaction with cell coreceptors: amino acids within the V1/V2 region of viral envelope are determinant for CCR8, CCR5 and CXCR4 usage.
    Santos-Costa Q; Lopes MM; Calado M; Azevedo-Pereira JM
    Retrovirology; 2014 Nov; 11():99. PubMed ID: 25421818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep Sequencing of the HIV-1 env Gene Reveals Discrete X4 Lineages and Linkage Disequilibrium between X4 and R5 Viruses in the V1/V2 and V3 Variable Regions.
    Zhou S; Bednar MM; Sturdevant CB; Hauser BM; Swanstrom R
    J Virol; 2016 Aug; 90(16):7142-58. PubMed ID: 27226378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative coreceptor requirements for efficient CCR5- and CXCR4-mediated HIV-1 entry into macrophages.
    Cashin K; Roche M; Sterjovski J; Ellett A; Gray LR; Cunningham AL; Ramsland PA; Churchill MJ; Gorry PR
    J Virol; 2011 Oct; 85(20):10699-709. PubMed ID: 21835796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C.
    Coetzer M; Nedellec R; Cilliers T; Meyers T; Morris L; Mosier DE
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):9-15. PubMed ID: 20921899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary infection by a human immunodeficiency virus with atypical coreceptor tropism.
    Jiang C; Parrish NF; Wilen CB; Li H; Chen Y; Pavlicek JW; Berg A; Lu X; Song H; Tilton JC; Pfaff JM; Henning EA; Decker JM; Moody MA; Drinker MS; Schutte R; Freel S; Tomaras GD; Nedellec R; Mosier DE; Haynes BF; Shaw GM; Hahn BH; Doms RW; Gao F
    J Virol; 2011 Oct; 85(20):10669-81. PubMed ID: 21835785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.
    Maeda Y; Takemura T; Chikata T; Kuwata T; Terasawa H; Fujimoto R; Kuse N; Akahoshi T; Murakoshi H; Tran GV; Zhang Y; Pham CH; Pham AHQ; Monde K; Sawa T; Matsushita S; Nguyen TV; Nguyen KV; Hasebe F; Yamashiro T; Takiguchi M
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32295903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.
    Arif MS; Hunter J; Léda AR; Zukurov JPL; Samer S; Camargo M; Galinskas J; Kallás EG; Komninakis SV; Janini LM; Sucupira MC; Diaz RS
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28659473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Env sequence determinants in CXCR4-using human immunodeficiency virus type-1 subtype C.
    Lin NH; Becerril C; Giguel F; Novitsky V; Moyo S; Makhema J; Essex M; Lockman S; Kuritzkes DR; Sagar M
    Virology; 2012 Nov; 433(2):296-307. PubMed ID: 22954962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection.
    Jakobsen MR; Cashin K; Roche M; Sterjovski J; Ellett A; Borm K; Flynn J; Erikstrup C; Gouillou M; Gray LR; Saksena NK; Wang B; Purcell DF; Kallestrup P; Zinyama-Gutsire R; Gomo E; Ullum H; Ostergaard L; Lee B; Ramsland PA; Churchill MJ; Gorry PR
    PLoS One; 2013; 8(6):e65950. PubMed ID: 23824043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain.
    Gray L; Roche M; Churchill MJ; Sterjovski J; Ellett A; Poumbourios P; Sherieff S; Wang B; Saksena N; Purcell DF; Wesselingh S; Cunningham AL; Brew BJ; Gabuzda D; Gorry PR
    J Virol; 2009 Jun; 83(11):5430-41. PubMed ID: 19321618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc.
    Borm K; Jakobsen MR; Cashin K; Flynn JK; Ellenberg P; Ostergaard L; Lee B; Churchill MJ; Roche M; Gorry PR
    Retrovirology; 2016 Nov; 13(1):74. PubMed ID: 27809912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations.
    Huang W; Eshleman SH; Toma J; Fransen S; Stawiski E; Paxinos EE; Whitcomb JM; Young AM; Donnell D; Mmiro F; Musoke P; Guay LA; Jackson JB; Parkin NT; Petropoulos CJ
    J Virol; 2007 Aug; 81(15):7885-93. PubMed ID: 17507467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Amino Acid Substitutions Within the V3 Region of HIV-1 CRF01_AE on Interaction with CCR5-Coreceptor.
    Hongjaisee S; Braibant M; Barin F; Ngo-Giang-Huong N; Sirirungsi W; Samleerat T
    AIDS Res Hum Retroviruses; 2017 Sep; 33(9):946-951. PubMed ID: 28497977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordant utilization of macrophage entry coreceptors by related variants within an HIV type 1 primary isolate viral swarm.
    Singh A; Yi Y; Isaacs SN; Kolson DL; Collman RG
    AIDS Res Hum Retroviruses; 2001 Jul; 17(10):957-63. PubMed ID: 11461681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.
    Jensen MA; Li FS; van 't Wout AB; Nickle DC; Shriner D; He HX; McLaughlin S; Shankarappa R; Margolick JB; Mullins JI
    J Virol; 2003 Dec; 77(24):13376-88. PubMed ID: 14645592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A formylpeptide receptor, FPRL1, acts as an efficient coreceptor for primary isolates of human immunodeficiency virus.
    Shimizu N; Tanaka A; Mori T; Ohtsuki T; Hoque A; Jinno-Oue A; Apichartpiyakul C; Kusagawa S; Takebe Y; Hoshino H
    Retrovirology; 2008 Jun; 5():52. PubMed ID: 18577234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.